10-Q Filing

TENET HEALTHCARE CORP CIK: 70318 Q2 2016

Filing Information

Form Type	10-Q
Accession Number	`0001558370-16-007064`
Period End Date	20160630
Filing Date	20160801
Fiscal Year	2016
Fiscal Period	Q2
XBRL Instance	thc-20160630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 95 Income Statement 131 Cash Flow Statement 95 Comprehensive Income 36

Balance Sheet 95 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, allowance for doubtful accounts (in dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$946.00M	USD	Point-in-time
Accounts receivable, allowance for doubtful accounts (in dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$887.00M	USD	Point-in-time
Property and equipment, accumulated depreciation and amortization (in dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$4.32B	USD	Point-in-time
Property and equipment, accumulated depreciation and amortization (in dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$4.81B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$656.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$356.00M	USD	Point-in-time
Other intangible assets, accumulated amortization (in dollars)	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$659.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$193.00M	USD	Point-in-time
Other intangible assets, accumulated amortization (in dollars)	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$734.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$299.00M	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts ($946 at June 30, 2016 and $887 at December 31, 2015)	`AccountsReceivableNetCurrent`	$2.70B	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts ($946 at June 30, 2016 and $887 at December 31, 2015)	`AccountsReceivableNetCurrent`	$2.73B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.05	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.05	USD	Point-in-time
Inventories of supplies, at cost	`InventoryNet`	$316.00M	USD	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	262.50M	shares	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	262.50M	shares	Point-in-time
Inventories of supplies, at cost	`InventoryNet`	$309.00M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	146.92M	shares	Point-in-time
Income tax receivable	`IncomeTaxesReceivable`	$3.00M	USD	Point-in-time
Income tax receivable	`IncomeTaxesReceivable`	$7.00M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	147.94M	shares	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$2.00M	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$550.00M	USD	Point-in-time
Common stock in treasury, shares	`TreasuryStockShares`	48.43M	shares	Point-in-time
Common stock in treasury, shares	`TreasuryStockShares`	48.42M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.25B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.28B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.17B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.99B	USD	Point-in-time
Investments and other assets	`LongTermInvestmentsAndReceivablesNet`	$1.18B	USD	Point-in-time
Investments and other assets	`LongTermInvestmentsAndReceivablesNet`	$1.32B	USD	Point-in-time
Deferred income taxes	`DeferredTaxAssetsNetNoncurrent`	$797.00M	USD	Point-in-time
Deferred income taxes	`DeferredTaxAssetsNetNoncurrent`	$776.00M	USD	Point-in-time
Property and equipment, at cost, less accumulated depreciation and amortization ($4,814 at June 30, 2016 and $4,323 at December 31, 2015)	`PropertyPlantAndEquipmentNet`	$7.98B	USD	Point-in-time
Property and equipment, at cost, less accumulated depreciation and amortization ($4,814 at June 30, 2016 and $4,323 at December 31, 2015)	`PropertyPlantAndEquipmentNet`	$7.92B	USD	Point-in-time
Goodwill	`Goodwill`	$7.29B	USD	Point-in-time
Goodwill	`Goodwill`	$6.97B	USD	Point-in-time
Other intangible assets, at cost, less accumulated amortization ($734 at June 30, 2016 and $659 at December 31, 2015)	`IntangibleAssetsNetExcludingGoodwill`	$1.68B	USD	Point-in-time
Other intangible assets, at cost, less accumulated amortization ($734 at June 30, 2016 and $659 at December 31, 2015)	`IntangibleAssetsNetExcludingGoodwill`	$1.86B	USD	Point-in-time
Total assets	`Assets`	$23.68B	USD	Point-in-time
Total assets	`Assets`	$24.24B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$181.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$127.00M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.38B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.27B	USD	Point-in-time
Accrued compensation and benefits	`EmployeeRelatedLiabilitiesCurrent`	$880.00M	USD	Point-in-time
Accrued compensation and benefits	`EmployeeRelatedLiabilitiesCurrent`	$843.00M	USD	Point-in-time
Professional and general liability reserves	`SelfInsuranceReserveCurrent`	$179.00M	USD	Point-in-time
Professional and general liability reserves	`SelfInsuranceReserveCurrent`	$177.00M	USD	Point-in-time
Accrued interest payable	`InterestPayableCurrent`	$205.00M	USD	Point-in-time
Accrued interest payable	`InterestPayableCurrent`	$205.00M	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$101.00M	USD	Point-in-time
Accrued legal settlement costs	`LitigationReserveCurrent`	$294.00M	USD	Point-in-time
Accrued legal settlement costs	`LitigationReserveCurrent`	$525.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.23B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.14B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.43B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.31B	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtAndCapitalLeaseObligations`	$14.38B	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtAndCapitalLeaseObligations`	$14.32B	USD	Point-in-time
Professional and general liability reserves	`SelfInsuranceReserveNoncurrent`	$613.00M	USD	Point-in-time
Professional and general liability reserves	`SelfInsuranceReserveNoncurrent`	$578.00M	USD	Point-in-time
Defined benefit plan obligations	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$594.00M	USD	Point-in-time
Defined benefit plan obligations	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$595.00M	USD	Point-in-time
Deferred income taxes	`DeferredTaxLiabilitiesNoncurrent`	$37.00M	USD	Point-in-time
Deferred income taxes	`DeferredTaxLiabilitiesNoncurrent`	$274.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$557.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$582.00M	USD	Point-in-time
Total liabilities	`Liabilities`	$20.81B	USD	Point-in-time
Total liabilities	`Liabilities`	$20.46B	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Redeemable noncontrolling interests in equity of consolidated subsidiaries	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$2.27B	USD	Point-in-time
Redeemable noncontrolling interests in equity of consolidated subsidiaries	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$2.27B	USD	Point-in-time
Common stock, $0.05 par value; authorized 262,500,000 shares; 147,937,909 shares issued at June 30, 2016 and 146,920,454 shares issued at December 31, 2015	`CommonStockValue`	$7.00M	USD	Point-in-time
Common stock, $0.05 par value; authorized 262,500,000 shares; 147,937,909 shares issued at June 30, 2016 and 146,920,454 shares issued at December 31, 2015	`CommonStockValue`	$7.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.82B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.79B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-203.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-164.00M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.66B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.55B	USD	Point-in-time
Common stock in treasury, at cost, 48,421,605 shares at June 30, 2016 and 48,425,298 shares at December 31, 2015	`TreasuryStockValue`	$2.42B	USD	Point-in-time
Common stock in treasury, at cost, 48,421,605 shares at June 30, 2016 and 48,425,298 shares at December 31, 2015	`TreasuryStockValue`	$2.42B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$523.00M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$691.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$629.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$267.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.02B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$958.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.15B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$785.00M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$23.68B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$24.24B	USD	Point-in-time

Income Statement 131 line items

Line Item	Tag	Value	Unit	Period
Net operating revenues before provision for doubtful accounts	`HealthCareOrganizationRevenue`	$5.22B	USD	1 Quarter
Net operating revenues before provision for doubtful accounts	`HealthCareOrganizationRevenue`	$9.63B	USD	2 Qtrs
Net operating revenues before provision for doubtful accounts	`HealthCareOrganizationRevenue`	$4.84B	USD	1 Quarter
Net operating revenues before provision for doubtful accounts	`HealthCareOrganizationRevenue`	$10.64B	USD	2 Qtrs
Less: Provision for doubtful accounts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$352.00M	USD	1 Quarter
Less: Provision for doubtful accounts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$352.00M	USD	1 Quarter
Less: Provision for doubtful accounts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$715.00M	USD	2 Qtrs
Less: Provision for doubtful accounts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$728.00M	USD	2 Qtrs
Net operating revenues	`HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions`	$4.49B	USD	1 Quarter
Net operating revenues	`HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions`	$4.87B	USD	1 Quarter
Net operating revenues	`HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions`	$9.91B	USD	2 Qtrs
Net operating revenues	`HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions`	$8.92B	USD	2 Qtrs
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$30.00M	USD	1 Quarter
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$54.00M	USD	2 Qtrs
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$16.00M	USD	1 Quarter
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$20.00M	USD	2 Qtrs
Salaries, wages and benefits	`LaborAndRelatedExpense`	$2.32B	USD	1 Quarter
Salaries, wages and benefits	`LaborAndRelatedExpense`	$4.72B	USD	2 Qtrs
Salaries, wages and benefits	`LaborAndRelatedExpense`	$4.31B	USD	2 Qtrs
Salaries, wages and benefits	`LaborAndRelatedExpense`	$2.19B	USD	1 Quarter
Supplies	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$1.58B	USD	2 Qtrs
Supplies	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$1.39B	USD	2 Qtrs
Supplies	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$707.00M	USD	1 Quarter
Supplies	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$773.00M	USD	1 Quarter
Other operating expenses, net	`OtherCostAndExpenseOperating`	$1.08B	USD	1 Quarter
Other operating expenses, net	`OtherCostAndExpenseOperating`	$2.46B	USD	2 Qtrs
Other operating expenses, net	`OtherCostAndExpenseOperating`	$2.17B	USD	2 Qtrs
Other operating expenses, net	`OtherCostAndExpenseOperating`	$1.21B	USD	1 Quarter
Electronic health record incentives	`ElectronicHealthRecordIncentives`	$-33.00M	USD	1 Quarter
Electronic health record incentives	`ElectronicHealthRecordIncentives`	$-21.00M	USD	1 Quarter
Electronic health record incentives	`ElectronicHealthRecordIncentives`	$-21.00M	USD	2 Qtrs
Electronic health record incentives	`ElectronicHealthRecordIncentives`	$-39.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$427.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$404.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$197.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$215.00M	USD	1 Quarter
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$22.00M	USD	1 Quarter
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$50.00M	USD	2 Qtrs
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$193.00M	USD	1 Quarter
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$222.00M	USD	2 Qtrs
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-114.00M	USD	1 Quarter
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-14.00M	USD	1 Quarter
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-17.00M	USD	2 Qtrs
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-287.00M	USD	2 Qtrs
Gains on sales, consolidation and deconsolidation of facilities	`GainLossOnSaleConsolidationAndDeconsolidationOfFacilities`	$1.00M	USD	1 Quarter
Gains on sales, consolidation and deconsolidation of facilities	`GainLossOnSaleConsolidationAndDeconsolidationOfFacilities`	$148.00M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$164.00M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$454.00M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$614.00M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$267.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$487.00M	USD	2 Qtrs
Interest expense	`InterestExpense`	$416.00M	USD	2 Qtrs
Interest expense	`InterestExpense`	$217.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$244.00M	USD	1 Quarter
Investment earnings (losses)	`GainLossOnInvestments`	$3.00M	USD	2 Qtrs
Investment earnings (losses)	`GainLossOnInvestments`	$2.00M	USD	1 Quarter
Investment earnings (losses)	`GainLossOnInvestments`	$-1.00M	USD	2 Qtrs
Investment earnings (losses)	`GainLossOnInvestments`	$-1.00M	USD	1 Quarter
Net income (loss) from continuing operations, before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$37.00M	USD	2 Qtrs
Net income (loss) from continuing operations, before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$130.00M	USD	2 Qtrs
Net income (loss) from continuing operations, before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-54.00M	USD	1 Quarter
Net income (loss) from continuing operations, before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$25.00M	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$51.00M	USD	2 Qtrs
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$-16.00M	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$-27.00M	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$-11.00M	USD	2 Qtrs
Net income (loss) from continuing operations, before discontinued operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-27.00M	USD	1 Quarter
Net income (loss) from continuing operations, before discontinued operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$48.00M	USD	2 Qtrs
Net income (loss) from continuing operations, before discontinued operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$41.00M	USD	1 Quarter
Net income (loss) from continuing operations, before discontinued operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$79.00M	USD	2 Qtrs
Loss from operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax`	$-2.00M	USD	1 Quarter
Loss from operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax`	$-7.00M	USD	2 Qtrs
Loss from operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax`	$-2.00M	USD	1 Quarter
Income tax benefit	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$-1.00M	USD	1 Quarter
Income tax benefit	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$-1.00M	USD	2 Qtrs
Net loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-2.00M	USD	1 Quarter
Net loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-6.00M	USD	2 Qtrs
Net loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-1.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$39.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$73.00M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$48.00M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-28.00M	USD	1 Quarter
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$33.00M	USD	1 Quarter
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$178.00M	USD	2 Qtrs
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$62.00M	USD	2 Qtrs
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$85.00M	USD	1 Quarter
Net loss attributable to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-105.00M	USD	2 Qtrs
Net loss attributable to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-61.00M	USD	1 Quarter
Net loss attributable to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-46.00M	USD	1 Quarter
Net loss attributable to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-14.00M	USD	2 Qtrs
Net loss from continuing operations, net of tax	`IncomeLossFromContinuingOperations`	$-14.00M	USD	2 Qtrs
Net loss from continuing operations, net of tax	`IncomeLossFromContinuingOperations`	$-44.00M	USD	1 Quarter
Net loss from continuing operations, net of tax	`IncomeLossFromContinuingOperations`	$-60.00M	USD	1 Quarter
Net loss from continuing operations, net of tax	`IncomeLossFromContinuingOperations`	$-99.00M	USD	2 Qtrs
Net loss from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-2.00M	USD	1 Quarter
Net loss from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-1.00M	USD	1 Quarter
Net loss from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-6.00M	USD	2 Qtrs
Net loss attributable to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-105.00M	USD	2 Qtrs
Net loss attributable to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-61.00M	USD	1 Quarter
Net loss attributable to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-46.00M	USD	1 Quarter
Net loss attributable to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-14.00M	USD	2 Qtrs
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-1.00	USD	2 Qtrs
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.14	USD	2 Qtrs
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.60	USD	1 Quarter
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.44	USD	1 Quarter
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.01	USD	1 Quarter
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.02	USD	1 Quarter
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.06	USD	2 Qtrs
Total loss per share, Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.61	USD	1 Quarter
Total loss per share, Basic (in dollars per share)	`EarningsPerShareBasic`	$-1.06	USD	2 Qtrs
Total loss per share, Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.14	USD	2 Qtrs
Total loss per share, Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.46	USD	1 Quarter
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.44	USD	1 Quarter
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.14	USD	2 Qtrs
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.60	USD	1 Quarter
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-1.00	USD	2 Qtrs
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.01	USD	1 Quarter
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.02	USD	1 Quarter
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.06	USD	2 Qtrs
Total loss per share, Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.46	USD	1 Quarter
Total loss per share, Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.06	USD	2 Qtrs
Total loss per share, Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.61	USD	1 Quarter
Total loss per share, Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.14	USD	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	98.97M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	99.05M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	99.24M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	99.34M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	98.97M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	99.34M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	99.24M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	99.05M	shares	2 Qtrs

Cash Flow Statement 95 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$39.00M	USD	1 Quarter
Net income	`ProfitLoss`	$73.00M	USD	2 Qtrs
Net income	`ProfitLoss`	$48.00M	USD	2 Qtrs
Net income	`ProfitLoss`	$-28.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$427.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$404.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$197.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$215.00M	USD	1 Quarter
Provision for doubtful accounts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$352.00M	USD	1 Quarter
Provision for doubtful accounts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$352.00M	USD	1 Quarter
Provision for doubtful accounts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$715.00M	USD	2 Qtrs
Provision for doubtful accounts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$728.00M	USD	2 Qtrs
Deferred income tax expense (benefit)	`DeferredIncomeTaxExpenseBenefit`	$37.00M	USD	2 Qtrs
Deferred income tax expense (benefit)	`DeferredIncomeTaxExpenseBenefit`	$-27.00M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$35.00M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$33.00M	USD	2 Qtrs
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$22.00M	USD	1 Quarter
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$50.00M	USD	2 Qtrs
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$193.00M	USD	1 Quarter
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$222.00M	USD	2 Qtrs
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-114.00M	USD	1 Quarter
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-14.00M	USD	1 Quarter
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-17.00M	USD	2 Qtrs
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-287.00M	USD	2 Qtrs
Gains on sales, consolidation and deconsolidation of facilities	`GainLossOnSaleConsolidationAndDeconsolidationOfFacilities`	$1.00M	USD	1 Quarter
Gains on sales, consolidation and deconsolidation of facilities	`GainLossOnSaleConsolidationAndDeconsolidationOfFacilities`	$148.00M	USD	2 Qtrs
Equity in earnings of unconsolidated affiliates, net of distributions received	`UndistributedEarnings`	$-10.00M	USD	2 Qtrs
Equity in earnings of unconsolidated affiliates, net of distributions received	`UndistributedEarnings`	$20.00M	USD	2 Qtrs
Amortization of debt discount and debt issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	$21.00M	USD	2 Qtrs
Amortization of debt discount and debt issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	$21.00M	USD	2 Qtrs
Pre-tax loss (income) from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-7.00M	USD	2 Qtrs
Other items, net	`OtherNoncashIncomeExpense`	$5.00M	USD	2 Qtrs
Other items, net	`OtherNoncashIncomeExpense`	$2.00M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$725.00M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$779.00M	USD	2 Qtrs
Inventories and other current assets	`IncreaseDecreaseInInventoriesAndOtherAssetsCurrent`	$-36.00M	USD	2 Qtrs
Inventories and other current assets	`IncreaseDecreaseInInventoriesAndOtherAssetsCurrent`	$30.00M	USD	2 Qtrs
Income taxes	`IncreaseDecreaseInIncomeTaxesReceivable`	$-9.00M	USD	2 Qtrs
Income taxes	`IncreaseDecreaseInIncomeTaxesReceivable`	$17.00M	USD	2 Qtrs
Accounts payable, accrued expenses and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-267.00M	USD	2 Qtrs
Accounts payable, accrued expenses and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-106.00M	USD	2 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$40.00M	USD	2 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$34.00M	USD	2 Qtrs
Payments for restructuring charges, acquisition-related costs, and litigation costs and settlements	`PaymentsForRestructuringAndLitigationCosts`	$86.00M	USD	2 Qtrs
Payments for restructuring charges, acquisition-related costs, and litigation costs and settlements	`PaymentsForRestructuringAndLitigationCosts`	$99.00M	USD	2 Qtrs
Net cash used in operating activities from discontinued operations, excluding income taxes	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-8.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$582.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$353.00M	USD	2 Qtrs
Purchases of property and equipment - continuing operations	`PaymentsToAcquirePropertyPlantAndEquipment`	$359.00M	USD	2 Qtrs
Purchases of property and equipment - continuing operations	`PaymentsToAcquirePropertyPlantAndEquipment`	$413.00M	USD	2 Qtrs
Purchases of businesses or joint venture interests, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$94.00M	USD	2 Qtrs
Purchases of businesses or joint venture interests, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$636.00M	USD	2 Qtrs
Proceeds from sales of facilities and other assets	`ProceedsFromDivestitureOfBusinesses`	$573.00M	USD	2 Qtrs
Proceeds from sales of marketable securities, long-term investments and other assets	`ProceedsFromSaleOfMarketableSecuritiesLongTermInvestmentsAndOtherAssets`	$24.00M	USD	2 Qtrs
Proceeds from sales of marketable securities, long-term investments and other assets	`ProceedsFromSaleOfMarketableSecuritiesLongTermInvestmentsAndOtherAssets`	$11.00M	USD	2 Qtrs
Purchases of equity investments	`PaymentsToAcquireEquityMethodInvestments`	$2.00M	USD	2 Qtrs
Purchases of equity investments	`PaymentsToAcquireEquityMethodInvestments`	$35.00M	USD	2 Qtrs
Other long-term assets	`PaymentsForProceedsFromProductiveAssets`	$3.00M	USD	2 Qtrs
Other items, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-2.00M	USD	2 Qtrs
Other items, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-1.00M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$54.00M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-985.00M	USD	2 Qtrs
Repayments of borrowings under credit facility	`RepaymentsOfLongTermLinesOfCredit`	$1.20B	USD	2 Qtrs
Repayments of borrowings under credit facility	`RepaymentsOfLongTermLinesOfCredit`	$1.31B	USD	2 Qtrs
Proceeds from borrowings under credit facility	`ProceedsFromLongTermLinesOfCredit`	$1.20B	USD	2 Qtrs
Proceeds from borrowings under credit facility	`ProceedsFromLongTermLinesOfCredit`	$1.20B	USD	2 Qtrs
Repayments of other borrowings	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$76.00M	USD	2 Qtrs
Repayments of other borrowings	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$1.99B	USD	2 Qtrs
Proceeds from other borrowings	`ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet`	$3.19B	USD	2 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$72.00M	USD	2 Qtrs
Distributions paid to noncontrolling interests	`PaymentsOfDividendsMinorityInterest`	$95.00M	USD	2 Qtrs
Distributions paid to noncontrolling interests	`PaymentsOfDividendsMinorityInterest`	$23.00M	USD	2 Qtrs
Proceeds from sale of noncontrolling interests	`ProceedsFromSaleOfInterestInCorporateUnit`	$15.00M	USD	2 Qtrs
Proceeds from sale of noncontrolling interests	`ProceedsFromSaleOfInterestInCorporateUnit`	$3.00M	USD	2 Qtrs
Purchase of noncontrolling interest	`PaymentsForRepurchaseOfRedeemableNoncontrollingInterest`	$177.00M	USD	2 Qtrs
Purchase of noncontrolling interest	`PaymentsForRepurchaseOfRedeemableNoncontrollingInterest`	$254.00M	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$3.00M	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$9.00M	USD	2 Qtrs
Other items, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-6.00M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$738.00M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-336.00M	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$106.00M	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$300.00M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$656.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$356.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$193.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$299.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$656.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$356.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$193.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$299.00M	USD	Point-in-time
Interest paid, net of capitalized interest	`InterestPaidNet`	$467.00M	USD	2 Qtrs
Interest paid, net of capitalized interest	`InterestPaidNet`	$385.00M	USD	2 Qtrs
Income tax payments, net	`IncomeTaxesPaidNet`	$29.00M	USD	2 Qtrs
Income tax payments, net	`IncomeTaxesPaidNet`	$8.00M	USD	2 Qtrs

Comprehensive Income 36 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$39.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$73.00M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$48.00M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-28.00M	USD	1 Quarter
Amortization of net actuarial loss included in net periodic benefit costs	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax`	$3.00M	USD	2 Qtrs
Amortization of net actuarial loss included in net periodic benefit costs	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax`	$3.00M	USD	1 Quarter
Amortization of net actuarial loss included in net periodic benefit costs	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax`	$5.00M	USD	2 Qtrs
Amortization of net actuarial loss included in net periodic benefit costs	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax`	$2.00M	USD	1 Quarter
Unrealized gains (losses) on securities held as available-for-sale	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$1.00M	USD	2 Qtrs
Unrealized gains (losses) on securities held as available-for-sale	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-2.00M	USD	1 Quarter
Unrealized gains (losses) on securities held as available-for-sale	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$1.00M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax`	$-43.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax`	$-41.00M	USD	2 Qtrs
Other comprehensive income (loss) before income taxes	`OtherComprehensiveIncomeLossBeforeTax`	$-42.00M	USD	1 Quarter
Other comprehensive income (loss) before income taxes	`OtherComprehensiveIncomeLossBeforeTax`	$6.00M	USD	2 Qtrs
Other comprehensive income (loss) before income taxes	`OtherComprehensiveIncomeLossBeforeTax`	$2.00M	USD	1 Quarter
Other comprehensive income (loss) before income taxes	`OtherComprehensiveIncomeLossBeforeTax`	$-37.00M	USD	2 Qtrs
Income tax expense related to items of other comprehensive income (loss)	`OtherComprehensiveIncomeLossTax`	$1.00M	USD	2 Qtrs
Income tax expense related to items of other comprehensive income (loss)	`OtherComprehensiveIncomeLossTax`	$1.00M	USD	1 Quarter
Income tax expense related to items of other comprehensive income (loss)	`OtherComprehensiveIncomeLossTax`	$2.00M	USD	2 Qtrs
Total other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-43.00M	USD	1 Quarter
Total other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$5.00M	USD	2 Qtrs
Total other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$2.00M	USD	1 Quarter
Total other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-39.00M	USD	2 Qtrs
Comprehensive net income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-4.00M	USD	1 Quarter
Comprehensive net income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-26.00M	USD	1 Quarter
Comprehensive net income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$34.00M	USD	2 Qtrs
Comprehensive net income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$53.00M	USD	2 Qtrs
Less: Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$178.00M	USD	2 Qtrs
Less: Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$33.00M	USD	1 Quarter
Less: Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$85.00M	USD	1 Quarter
Less: Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$62.00M	USD	2 Qtrs
Comprehensive loss attributable to Tenet Healthcare Corporation common shareholders	`ComprehensiveIncomeNetOfTax`	$-59.00M	USD	1 Quarter
Comprehensive loss attributable to Tenet Healthcare Corporation common shareholders	`ComprehensiveIncomeNetOfTax`	$-9.00M	USD	2 Qtrs
Comprehensive loss attributable to Tenet Healthcare Corporation common shareholders	`ComprehensiveIncomeNetOfTax`	$-89.00M	USD	1 Quarter
Comprehensive loss attributable to Tenet Healthcare Corporation common shareholders	`ComprehensiveIncomeNetOfTax`	$-144.00M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.